Ksilink's Governance
  1. Home
  2.  » Governance

Ksilink’s Governance

Truly committed

Ksilink’s governance reflects its strong partnership between the public and private sectors. Our Board of Directors and committees ensure translational feasibility, market access and sustainability.

Ksilink’s founder and chairmen

Ksilink has been founded in 2014 by Ulf Nehrbass and was presided by André Syrota in order to translate scientific excellence into tangible results for the pharmaceutical industry. Since 2019 Alain Beretz is president of the Ksilink association.

Alain Beretz

Alain Beretz

Chairman, Ksilink

Ulf Nehrbass

Ulf Nehrbass

Founder and Strategic Advisor, Ksilink

André Syrota

André Syrota

Honorary Chairman, Ksilink

Ksilink’s board of directors

Andreas Meyer-Lindenberg

Andreas Meyer-Lindenberg

Director General, Central Institute for Mental Health (ZI)

Bert M. Klebl

Bert M. Klebl

Managing Director, Lead Discovery Center GmbH

Claudia Mayer

Claudia Mayer

Coordinator International Cooperations, German Cancer Research Center (DKFZ)

Franck Lethimmonier

Franck Lethimmonier

Health Technologies Institute Director, INSERM

Jacques Volckmann

Jacques Volckmann

Head of R&D France, Sanofi

Caroline Dreyer

Caroline Dreyer

General Manager, BioValley France

Michael Platten

Michael Platten

Director of the Mannheim Institute for Translational Neurosciences, University of Heidelberg

Michel de Mathelin

Michel de Mathelin

Vice President, University of Strasbourg

Oliver Brüstle, Prof. Dr.

Oliver Brüstle, Prof. Dr.

CEO, Life & Brain GmbH Professor of Reconstructive Neurobiology, Bonn Medical Center

Ralf Kindervater

Ralf Kindervater

CEO, BioPro Baden Württemberg GmbH

Serge Braun

Serge Braun

CSO, AFM Téléthon

Wolfram Zimmermann, Prof. Dr.

Wolfram Zimmermann, Prof. Dr.

Professor of Pharmacology at Goettingen Medical School CSO, Myriamed GmbH

Ksilink’s Independent Scientific Advisors Committee

Thierry Dorval

Thierry Dorval

Head of Data Sciences & Data Management, Servier

Christine Klein

Christine Klein

Director, Institute of Neurogenetics, University of Lübeck

Alleyn Plowright

Alleyn Plowright

CSO and Drug Discovery Leader, Pangea Bio

Thomas Thum, Prof. Dr.

Thomas Thum, Prof. Dr.

Professor of Cardiology, Hannover Medical School Founder, CSO/CMO Cardior Pharmaceuticals GmbH